亚洲在线日韩伦理片,96精品国产AⅤ一区二区,青鸟影视网,yy黄色频道,国内精品久久久精品AV电影院

大睿生物醫藥科技（上海）有限公司

Latest News

Rona Therapeutics Announces IND Filing of RN3161, a Highly Potent and Durable INHBE siRNA for Obesity

 SHANGHAI and SANTA BARBARA, Calif., Sept. 15, 2025 /PRNewswire/ -- Rona Therapeutics, a global lead...

2025-09-15 20:00 1157

Rona Therapeutics Announces Breakthrough Data on Potential Annual Dosing RNAi Therapy RN026 Targeting Lipoprotein(a) in The National Lipid Association (NLA) Scientific Sessions 2025

 SHANGHAI, May 29, 2025 /PRNewswire/ -- Rona?Therapeutics, a global leading RNA therapy company, tod...

2025-05-29 20:00 1697

Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension

 SHANGHAI, April 21, 2025 /PRNewswire/ --?Rona Therapeutics, a biotechnology company pioneering inno...

2025-04-21 19:00 2634

Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia

 SHANGHAI, March 17, 2025 /PRNewswire/ --?Rona Therapeutics Inc., a global leader in RNA-targeted th...

2025-03-17 19:00 3528

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

 * Single dose of RN0191 achieved up to 95% individual maximum and 87% mean maximum PCSK9 reductio...

2024-11-18 09:00 2815

Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms

 * Financing led by LongRiver Investments with participation by new and existing global investment...

2024-07-19 12:30 3715

Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis

 SHANGHAI, May 15, 2023 /PRNewswire/ -- Rona Therapeutics, Inc ("Rona") and Keymed Biosciences ("Key...

2023-05-15 12:30 3217

Rona Therapeutics Announces Exclusive Licensing Transaction from Sanofi for its Broad siRNA Therapeutic Portfolio and Technology Platform

 * Rona to advance worldwide development of Sanofi siRNA portfolio targeting liver and other tissu...

2022-07-25 12:30 3199

Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics

 - Funding from long-term investors to build leading delivery platform and scalable drug discovery e...

2022-04-07 12:30 3330